Harte-Hanks (HHS) has a profit margin of -3.19%, below the Consumer Discretionary sector average of 4.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for HHS is -3.19% as of September 2026. That compares with -79.81% in the prior-year period — up 96.0% year over year. That is below the Consumer Discretionary sector average of 4.34%. Investors often review this figure alongside Harte-Hanks's historical trend and sector peers before judging valuation or financial health.
Over the past year, HHS's profit margin moved from -79.81% to -3.19% — a 96.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harte-Hanks's valuation or profitability profile.
Against Consumer Discretionary companies, HHS currently prints -3.19% for profit margin, while the sector average sits near 4.34%. That is roughly 173.6% below the sector mean. Large gaps often invite a closer look at Harte-Hanks's growth, margins, and balance sheet.
Profit Margin shows how effectively Harte-Hanks converts resources into returns. At -3.19%, HHS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -79.81% in the prior-year period — up 96.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting HHS's profit margin (-3.19%), review year-over-year change from -79.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.